Guardian Pharmacy Services (GRDN) vs 111 (YI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Guardian Pharmacy Services (GRDN) has outperformed 111 (YI) over the past year, gaining 71.4% versus a loss of 33.1%. Guardian Pharmacy Services is the larger company by market cap ($2.58 billion vs $27.7 million), about 93.0 times the size. On valuation, 111 trades at a lower forward P/E (22.5x vs 28.4x for Guardian Pharmacy Services).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GRDN | YI |
|---|---|---|
| Share price | $40.68 | $3.15 |
| Market cap | $2.58B | $27.71M |
| 1-day change | -1.26% | +1.94% |
| YTD return | +35.19% | +23.05% |
| 1-year return | +71.36% | -33.12% |
| 5-year return | — | -44.25% |
| P/E ratio (TTM) | 39.50 | 0.31 |
| Forward P/E | 28.36 | 22.50 |
| EPS (TTM) | $1.03 | $10.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $48.33 | $11.17 |
| 52-week low | $23.14 | $2.48 |
| Distance from 52-week high | -15.83% | -71.80% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +22.57% | — |
| Average volume | 473.34K | 11.48K |
| Shares outstanding | 63.32M | 5.20M |
| Employees | 3,600 | — |
| Sector | Consumer Staples | Consumer Staples |
| Industry | Retail-Drug Stores and Proprietary Stores | Retail-Drug Stores and Proprietary Stores |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Guardian Pharmacy Services is about 93.0 times larger than 111 by market value ($2.58B vs $27.71M).
- GRDN has outperformed YI by 104.5 percentage points over the past year.
- Guardian Pharmacy Services trades at a higher earnings multiple (39.5x vs 0.3x trailing P/E).
About Guardian Pharmacy Services
GRDN stock →Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes.
Consumer Staples · Retail-Drug Stores and Proprietary Stores · 3,600 employees
GRDN vs YI FAQ
Which is bigger, Guardian Pharmacy Services or 111?
Guardian Pharmacy Services (GRDN) is larger, with a market capitalization of $2.58B compared with $27.71M for 111 (YI).
Which stock has performed better over the past year, GRDN or YI?
GRDN returned +71.36% over the past 12 months, compared with -33.12% for YI (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, GRDN or YI?
YI has the lower trailing P/E at 0.3, versus 39.5 for GRDN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Guardian Pharmacy Services and 111 in the same industry?
Yes. Both are classified in the Retail-Drug Stores and Proprietary Stores industry within the Consumer Staples sector.